Highlights From AACR IO 2026: Breaching the Tumor Microenvironment Fortress With New CAR T and Chimeras
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Category: Meetings
Three innovative studies at AACR IO 2026 presented new ways for CAR T cells and antibody-lectin chimeras to tackle...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Researchers and a patient advocate weighed in on current and emerging treatment options for each stage of triple-negative breast...
What are fusion proteins? Learn more about how improperly combined genes and their protein products can lead to cancer.
At an AACR special conference on early-onset cancers, researchers discussed microplastics, the global rise of these cancers, and more.
An AACR Special Conference on early-onset cancers explored possible explanations for the alarming increase in cancer among younger adults.
At the SABCS 2025 View From the Trenches session, experts discussed how new clinical trial results might transform breast...
At SABCS 2025, studies show some patients with early-stage breast cancer can skip steps like SLNB or MRI without...
In clinical trials presented at SABCS, a mobile health tool and acupuncture helped to improve breast cancer survivors' quality...
Amid the debate over menopausal hormone therapy and cancer risk, researchers at SABCS provided some clarity for women with...